FTSE 100 today: Index rises, GBP flat; Mitchells & Butlers jumps, Whitbread falls
DUBLIN - Investment firm Geode Capital Management, LLC has disclosed a 2.24% stake in Avadel Pharmaceuticals plc, according to a regulatory filing published Tuesday.
The disclosure, made under Irish Takeover Panel rules, shows Geode holds 2,194,154 ordinary shares in the pharmaceutical company as of November 24, 2025.
The filing also revealed that Geode purchased 4,784 additional Avadel shares at $23.03 per unit in its most recent transaction.
The disclosure was made in accordance with Rule 8.3 of the Irish Takeover Panel Act, which requires persons with interests in relevant securities representing 1% or more to disclose their positions.
Geode Capital Management, a global investment management firm, indicated in the filing that it has no indemnity arrangements, options, or other agreements relating to Avadel’s securities.
The disclosure comes in the form of an opening position statement, which is typically required when a company becomes subject to takeover rules. However, the filing does not specify whether Avadel is currently involved in any takeover discussions or proceedings.
Avadel Pharmaceuticals is a biopharmaceutical company headquartered in Ireland that focuses on developing and commercializing pharmaceutical products.
The information was disclosed in a regulatory filing submitted to the Irish Takeover Panel.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.